Monday, September 17, 2018 7:11:23 PM
This is one of the issues I have regarding the rampant speculation around here, and given the ultra-confusing PR coming out of IPIX, I find it hard to understand how folks seem to be able to extrapolate much from the limited data provided on their end.
Much is negotiable if both parties agree when it comes to writing contracts, so we literally have no idea what's on the table (aside from what was stated in the recent announcement), timelines etc. I'm guessing that a BP would; having seen IPIX's 10-K etc, have an understanding of the timeliness of a deal and what that would likely mean for IPIX's existential concerns.
The other notion that 'the company isn't worth anything if the SP is in the toilet' is a little confusing.
The BP would be interested in their patent-developments and trial-progress.
They're not purchasing IPIX's ability to run an accounting firm or business consultancy... They're after drugs for their own inventory to either augment existing products, remove a competitive situation (CELG/Otezla), or expanding the scope of their current portfolios.
Based on where things stand currently, small-trial-sizes excepted, we have progress that's likely of interest on some level to some global players (https://clinicaltrials.gov/ct2/results?term=cellceutix&Search=Search)
Patents are worth $. Management may or may not be asked to stick around in the event of a buyout/M&A situation... we have no idea. The drugs are the value. SP doesn't reflect current value.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM